Latest News

The leading space company just released another strong earnings report, but it still has some issues.

For many buy-and-hold investors just getting started, knowing how to understand businesses better is one of the first skills to develop. One term that the financial world has developed for business strengths is economic moat, which means something that keeps competitors from posing a real threat to a business.

Coca-Cola has had its best year since 1996.

Operating leverage from cost cuts is now compounding with margin expansion, a dual engine for earnings growth.

Multiyear renewal rates and AI-driven automation are expanding both customer stickiness and margin potential simultaneously.

The numbers paint a clear picture for shareholders.

Retirees in their 70s receive substantially more per month, but the gap reflects claiming patterns and lifetime earnings rather than automatic growth.

Management's pivot to commercial lending and fee income hinges on whether the bank can execute a balance sheet overhaul under new leadership.

Dow's $14 billion liquidity cushion through 2029 give it financial flexibility competitors may lack during uncertain cycles.

Mizuho upgraded Albemarle to Outperform with a $130 target, citing battery storage demand and low-cost production ahead of its Nov. 4 earnings report.

Things continue to get more exciting for Elon Musk's brainchild.

These funds each provide a different approach to inflation protection in your portfolio.

Aclara Resources (TSE:ARA) outlined plans to build an integrated rare-earth supply chain spanning two ionic-clay deposits in South America, a separation facility in Louisiana and a metals-and-alloys operation, with management emphasizing its focus on heavy rare earth elements including dysprosium, t

Micron is changing more toward contracts, rather than letting the open market dictate pricing.

If you're on Medicare, this is an opportunity you don't want to miss.

Royalty Pharma invests in a portfolio of drugs, from blockbusters to those still in development.

Coca-Cola, Monster Beverage, and Keurig Dr. Pepper have each gained at least 20% YTD as beverages lead a consumer staples rebound, with all three reporting Q3 2026 earnings soon.

Eaton combines AI-driven growth with an established, profitable industrial business.

Taiwan Semiconductor is likely to be one of the best performing AI stocks in the next few years.

There are numerous nuclear stocks to consider. Ark Invest has its eyes on two in particular.

Intel's margins are rising, which could drive significant earnings growth.

Lexeo Therapeutics (NASDAQ:LXEO) outlined upcoming clinical and regulatory milestones for its gene therapy programs in Friedreich’s ataxia cardiomyopathy and PKP2-associated arrhythmogenic cardiomyopathy during the Chardan Healthcare Conference. Chief Financial Officer Lou Tamayo said the clinical-

The S&P 500 might be vulnerable to a 20% bear market decline, given the growing number of risks.

Volatility is a recurring theme in this company's story line.

Planet Fitness shares have slumped amid slowing membership growth and AI-related concerns, but analysts see over 30% upside ahead of third-quarter earnings on Nov. 5.